sábado, 28 de marzo de 2020

Vir Biotechnology reports early progress in antibody treatment for Covid-19

Vir Biotechnology reports early progress in antibody treatment for Covid-19

Daily Recap

Vir Biotechnology reports early progress in antibody treatment for Covid-19

By MATTHEW HERPER


NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH
The company, which is working with the Cambridge, Mass., biotech firm Biogen, said that human tests of the drugs could begin in three to five months.

No hay comentarios: